Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing clinician participation in quality improvement training: implementation and impact of an evidence-based initiative to maximise antenatal clinician participation in training regarding women's alcohol consumption during pregnancy.

BMC health services research·2022
Same author

Community Priority setting for Fetal Alcohol Spectrum Disorder Research in Australia.

International journal of population data science·2021
Same author

Characterization of transient noise in Advanced LIGO relevant to gravitational wave signal GW150914.

Classical and quantum gravity·2020
Same author

GW150914: First results from the search for binary black hole coalescence with Advanced LIGO.

Physical review. D. (2016)·2020
Same author

[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS].

Klinicheskaia meditsina·2018
Same author

The effect of hydrogen sulfide-releasing naproxen (ATB-346) versus naproxen on formation of stress-induced gastric lesions, the regulation of systemic inflammation, hypoxia and alterations in gastric microcirculation.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018

Related Experiment Video

Updated: Jul 8, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

Do eicosanoids cause colonic dysfunction in experimental E coli O157:H7 (EHEC) infection?

C J Bell1, E J Elliott, J L Wallace

  • 1Department of Gastroenterology, Royal North Shore Hospital, St Leonards, Australia. cbell@med.usyd.edu.au

Gut
|May 16, 2000
PubMed
Summary
This summary is machine-generated.

Enterohaemorrhagic Escherichia coli (EHEC) infection's impact on the colon is complex. Prostaglandin E(2) and leukotriene B(4) do not directly correlate with EHEC colitis inflammation or permeability changes.

More Related Videos

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions
07:46

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions

Published on: March 10, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

Related Experiment Videos

Last Updated: Jul 8, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions
07:46

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions

Published on: March 10, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The precise mechanisms driving enterohaemorrhagic Escherichia coli (EHEC) infection pathophysiology are not fully understood.
  • Eicosanoids, including prostaglandin E(2) (PGE(2)) and leukotriene B(4) (LTB(4)), are implicated in the pathology of other colitis conditions.

Purpose of the Study:

  • To investigate the role of prostaglandin E(2) (PGE(2)) and leukotriene B(4) (LTB(4)) in the development of mucosal inflammation and dysfunction during EHEC colitis.
  • To determine the temporal relationship between eicosanoid synthesis and changes in mucosal barrier function and ion transport.

Main Methods:

  • Experimental infection of rabbits with EHEC, followed by measurement of colonic prostaglandin E(2) (PGE(2)) and leukotriene B(4) (LTB(4)) synthesis.
  • Assessment of in vivo intestinal permeability using (51)Cr-EDTA, myeloperoxidase activity, and histological analysis of mucosal damage.
  • Evaluation of ion transport in Ussing chambers and the effects of cyclooxygenase and lipoxygenase inhibitors on EHEC-induced changes.

Main Results:

  • Leukotriene B(4) (LTB(4)) synthesis increased early post-infection, while prostaglandin E(2) (PGE(2)) synthesis increased later.
  • Increased mucosal permeability and histological damage were observed at day 5 post-infection, not correlating with early eicosanoid changes.
  • Inhibition of LTB(4) synthesis did not alter inflammation or diarrhea, whereas cyclooxygenase inhibition partially reversed ion transport abnormalities.

Conclusions:

  • Tissue synthesis of prostaglandin E(2) (PGE(2)) and leukotriene B(4) (LTB(4)) does not show a direct temporal correlation with EHEC-induced inflammation or mucosal dysfunction.
  • The findings suggest a more intricate role for eicosanoids in EHEC colitis than previously hypothesized.
  • Cyclooxygenase inhibition offers partial reversal of ion transport defects, while lipoxygenase inhibition shows no effect on inflammation or damage.